Authors

  • Rasulov H.A., Primova G.A., Subkhanova M.G.

Keywords:

glucocorticoids, dexamethasone, femoral head, vasculopathy, microcirculation, osteonecrosis, pathomorphology, experimental study.

References

1. Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum. 2002;32(2):94–124.

2. Bassett JHD, Williams GR. Role of thyroid hormones in bone. Nat Rev Endocrinol. 2016;12:135–146.

3. Canalis E. Mechanisms of glucocorticoid-induced osteoporosis. Curr Opin Rheumatol. 2003;15(4):454–457.

4. Chen J, et al. Experimental steroid-induced osteonecrosis. Bone Joint Res. 2020;9:392–402.Dalle Carbonare L, et al. Bone microarchitecture in glucocorticoid-treated patients. Bone. 2005;36:912–920.

5. Drescher W, et al. Steroid-related osteonecrosis. Clin Orthop Relat Res. 2000;370:295–307.

6. Evans RM. The steroid and thyroid hormone receptor superfamily. Science. 1988;240:889–895.

7. Fukushima W, et al. Nationwide epidemiologic survey of osteonecrosis. Clin Orthop Relat Res. 2010;468:2715–2724.

8. Jalilov MK, Khudaykulova SN, Khamroev JK, Akhrorov MN, Jalilov HM. Guidelines for independent work on determination of the coefficient of internal friction of liquids. In: Proceedings of the International Scientific and Current Research Conferences; 2020. p. 36–38.

9. Jalilov MK, Nabiev AA, Jalilov HM. Determining the presence of the element 40Ca in the mixture using the (γ, Xγ)-reaction. Texas Journal of Engineering and Technology. 2022;13:13–15.

10. Khamidov OA, Ametova AS. Features of ultrasonographic findings of the radius and small joints of the hand in patients with rheumatoid arthritis and erosive osteoarthritis. Uzbek Journal of Case Reports. 2022;27.

11. Khamidov OA, Ravshanov ZK. Osteonecrosis of the femoral head after COVID-19: A case series. Uzbek Journal of Case Reports. 2023;13.

12. Lane NE. Glucocorticoid-induced osteoporosis. Endocrinol Metab Clin North Am. 2006;35:213–226.

13. Lane NE. Glucocorticoid-induced osteoporosis and osteonecrosis. Curr Opin Rheumatol. 2019;31:417–423.

14. Li J, et al. Mechanisms of glucocorticoid-induced bone injury. Front Endocrinol. 2021;12:679672.

15. Li Z, et al. Osteonecrosis and angiogenesis imbalance. Biomed Pharmacother. 2023;161:114548.

16. Mamatkulov K, Kholkhudjayev F, Mansurov D, Jalilov K, Kaxxorov A.Mont MA, Jones LC, Hungerford DS. Nontraumatic osteonecrosis of the femoral head. J Bone Joint Surg Am. 2006;88:1117–1132.

17. Motomura G, et al. Histopathological analysis of steroid-induced osteonecrosis. Mod Rheumatol. 2011;21:16–23.

18. Powell C, et al. Vascular pathology in osteonecrosis. Bone Res. 2021;9:36.Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum. 1996;39:1791–1801.

19. Soroka NF. Clinical use of glucocorticosteroid hormones: Application of betamethasone group medications. Recipe. 1998;(1):39–47.

20. Strachunsky LS, Kozlov SN. Glucocorticoid Drugs. Smolensk; 1997. 64 p.Trueta J. The normal vascular anatomy of the human femoral head. J Bone Joint Surg Br. 1957;39-B:358–394.